Search Ontology:
ChEBI

EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor

Term ID
CHEBI:68640
Synonyms
  • 17-alpha-hydroxylase/C17,20-lyase inhibitor
  • 17-alpha-hydroxylase/C17,20-lyase inhibitors
  • 17alpha-hydroxylase-C17,20 lyase inhibitor
  • 17alpha-hydroxylase-C17,20 lyase inhibitors
  • CYP17 inhibitor
  • CYP17 inhibitors
  • CYP17A1 inhibitor
  • CYP17A1 inhibitors
  • cytochrome P-45017alpha inhibitor
  • cytochrome P-45017alpha inhibitors
  • cytochrome P450 (P-45017alpha,lyase) inhibitor
  • cytochrome P450 (P-45017alpha,lyase) inhibitors
  • cytochrome P450 17-alpha-hydroxylase/C17,20-lyase inhibitor
  • cytochrome P450 17-alpha-hydroxylase/C17,20-lyase inhibitors
  • cytochrome p450 XVIIA1 inhibitor
  • cytochrome p450 XVIIA1 inhibitors
  • EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitors
  • EC 1.14.99.9 inhibitor
  • EC 1.14.99.9 inhibitors
  • steroid 17alpha-hydroxylase inhibitor
  • steroid 17alpha-hydroxylase inhibitors
  • steroid 17alpha-monooxygenase (EC 1.14.99.9) inhibitor
  • steroid 17alpha-monooxygenase (EC 1.14.99.9) inhibitors
  • steroid 17alpha-monooxygenase inhibitor
  • steroid 17alpha-monooxygenase inhibitors
  • steroid 17alphahydroxylase/17,20 lyase inhibitor
  • steroid 17alphahydroxylase/17,20 lyase inhibitors
  • steroid,NADPH--hemoprotein reductase:oxygen oxidoreductase (17alpha-hydroxylating) inhibitor
  • steroid,NADPH--hemoprotein reductase:oxygen oxidoreductase (17alpha-hydroxylating) inhibitors
Definition
An EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor that interferes with the action of cytochrome P450 17-alpha-hydroxylase/C17,20-lyase (EC 1.14.99.9).
References
Ontology
ChEBI  ( EBI )
Relationships
is a type of
inverse has_role
Phenotype
Phenotype resulting from EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor
Phenotype where environments contain EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor
Phenotype modified by environments containing EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor
Human Disease Model